January 3rd Biotech Update

2021 is finally over and 2022 enters with hopes of a better year but we all are probably scarred from the year that was 2021.  JPM is coming and that brings with it hopes of M&A, positive guidance, and perhaps positive data.  Last year it was not great and that ended up being a signal […]

August 23rd Biotech Update

What is happening?  Do we actually have M&A that could be more broadly meaningful for the sector?  I think we might actually have had one.  Obviously we need to see how the sector ultimately reacts to the deal but it is setup as being really good for the sector and not just for one day […]

August 18th Biotech Update

Not a ton of more that is going on in the sector.  It was certainly nice to see the green but we really need that momentum to continue.  I still think the sector is best described as either range bound or potentially starting a new downtrend.  I lean towards the range bound but it also […]

August 12th Biotech Update

I painted such a nice story yesterday with a setup that was going to move us higher into a long awaited uptrend and then the sector did what the sector has been doing all year.  I still think we are setup to get a bull market going but nothing is going to be easy for […]

July 23rd Biotech Update

There is nothing yesterday that has dissuaded me of my negative view of the sector.  It is always possible that the downtrend ends but my mantra is always that assume trends remain until proven otherwise.  As such my base case (until shown otherwise) is that the sector is going to making its way to a […]

June 24th Biotech Update

The sector is hot today and it is not precisely clear as to why.  There has been some news that seems to be read as positive but this still looks to me like a sector that lacks a clear conviction.  Usually you could see a day like this and then expect some positive momentum for […]

June 19th Biotech Update

I think the sector is setting up well if we can break above the $138 level in the near term.   Yes, we had a couple days of weakness earlier this week but the recent strength (modest as it has been) is setting up that weakness as a potential higher low.  This become more likely if […]

June 9th Biotech Update

We had a nice little ramp to end yesterday and hopefully that is a sign of some building momentum in the sector.  There are good reasons for us to get some positive momentum with the BIIB approval (it is probably the largest positive surprise this year) and the broader market is likely supportive as well […]

February 3rd Biotech Update

It seems like the reddit traders and the GME short squeeze neither broke the market or revolutionized it.  They were unable to keep the price high and avoid the crash (I suspect the Robinhood restriction only hastened the crash) and the were unable to replicate it in their next target of SLV.  So odds are […]

September 30th Biotech Update

Given the importance of the election in terms of the market, one would have expected that the debate last night would have an impact on the market.  I have no idea how to interpret what happened last night in terms of who won or what they would actually do if elected.  The markets last night […]

May 1st Biotech Update

We finally get two days in a row of the same move but unfortunately it is down.  This is not completely surprising as it is completely reasonable that the sharp move higher in the market needs to pause and/or retrench a little.  Of course, the tension and worry will be whether or not this is […]

April 30th Biotech (and MLP) Update

We continue with a back and forth week.  I think we have alternated up and down days this entire week.  This continues day and clearly we have a week of indecision.  This is not necessarily bullish.  Yes, it is bullish to basically digest a move higher with sideways action but the news this week has […]

April 29th Biotech Update

Yesterday was a retracement day and seemed almost like a rotation out of what was working (biotech) into lagging sectors (banking).  Given the strength in the sector it should be able to handle the retracement before continuing the move higher.  The only worry is the XBI compared to the IBB.  The IBB had made new […]

April 27th Biotech Update

A new week and it is off to a good start.  One debate I often have with myself is whether or not the bottom is in.  It is an important question but really unknowable at this point.  If HCQ or remdisivr or some other drug comes out as a reasonable treatment for COVID between now […]

April 24th Biotech (and MLP) Update

It seems like the market is slowly getting back to some sort of normalcy.  The daily massive moves are slowly becoming more measured moves.  Yes, volatility is still elevated and we still get large moves but the days of daily 5%-10% moves higher or lower with even larger swings seems to be slowly moving into […]

April 23 Biotech (and MLP) Update

Good news for investors.  Stocks have never been red when weekly jobless claims were over 3 million and with the 4+ million claims this week, we should be fine.  Clearly we are in abnormal times but simply looking the at the price action and ignoring the broader economic fundamentals, the market is strong.  That seems […]

April 20th Biotech (and MLP) Update

So it looked like last week finally decided the next move would be higher but this morning we start with some weakness.  I would not be surprised, however, to see the market to reverse during the day.  I saw an analysis that showed almost all of the downside on the selloff the past couple months […]

April 7 Biotech Update

So the crisis is over!  Or at least that is the way the markets are behaving.  It is pretty clear that we are having a reversal of the COVID sell-offs.  The market is moving higher including and perhaps being led by regional banks and all those COVID related names (whether it be treatments, PPE, or […]

April 3rd Biotech Update

Guess what?  Job market sucks.  The market dipped a little on that news which I find a little surprising as nothing about it should have surprised.  What was interesting was that the US indicated that its oil producers were willing to cut production as a carrot to get Russia on board.  I do not remember […]